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Abstract
Individuals with adult attention-deficit/hyperactivity disorder (ADHD) present with
deficits in attention, hyperactivity-impulsivity, or a combination of these symptoms.
Functional impairment due to inattention, reduced motivation, poor impulse control,
emotion dysregulation, and deficits in executive functioning are also frequently seen.
Assessment of ADHD, using objective continuous performance tasks, has been
introduced in conjunction with widely used self-report measures of ADHD symptom
severity. The Conner’s Adult ADHD Rating Scale (CAARS) is one such self-report
measure of ADHD, consisting of 66 self-report items that measure symptoms of ADHD,
including inattention, hyperactivity, impulsivity, and poor self-concept. The Quotient
ADHD System purports to provide objective measures of ability to inhibit motor activity,
maintain attention, and suppress impulsive responses. The Quotient ADHD System has
been found to be sensitive to the pharmacologic effects of ADHD medication. Currently,
there is a lack of empirical evidence for the Quotient ADHD System in an adult
population, specifically, indicating a relationship between evaluations using the Quotient
ADHD System and a widely accepted self-report measurement of ADHD, such as the
CAARS. The present study determined that the global scaled score and motion scaled
score metrics of the Quotient ADHD System correlate with the Hyperactive/Restlessness
scale on the CAARS. Furthermore, the present study found a significant positive
correlation between the Inattentive Metric of the Quotient ADHD System and the
Inattention/Memory scale on the CAARS.
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Introduction
Attention-deficit/hyperactivity disorder (ADHD) is a pervasive
neurodevelopmental disorder that persists from childhood through adulthood for up to
60% of individuals (5th ed., DSM–5; American Psychiatric Association [APA], 2013;
Agnew-Blais, Seidman, & Buka, 2013; Kessler et al., 2006; Rowland et al., 2015).
According to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition,
(APA, 2013), ADHD is a persistent pattern of inattentiveness, hyperactivity-impulsivity,
or a combination of the two.
According to the DSM−5 criteria, a diagnosis of ADHD includes six or more
symptoms in children, or five or more symptoms in adults, that persist for over 6 months
and negatively impact academic, occupational, or social activities (APA, 2013).
Symptoms of inattention have been characterized as failure to give attention to detail,
difficulty sustaining attention in tasks, appearing absent-minded even when spoken to
directly, failure to follow through on instructions or schoolwork or occupation-related
tasks, difficulty organizing tasks, avoidance of attentionally demanding tasks, losing
things, distractibility, and forgetfulness (APA, 2013). Symptoms of hyperactivity and
impulsiveness have been characterized as fidgeting, difficulty remaining seated, feelings
of restlessness in adults or overactivity in children, difficulty engaging in leisure
activities quietly, discomfort with sitting still for extended periods of time, excessive
talking, interruption in conversation, difficulty waiting their turn, and frequent intrusion
on others’ activities (APA, 2013).
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The predominately inattentive subtype of ADHD is characterized by the presence
of six or more symptoms related to inattention in children or five or more of the
symptoms in adolescents or adults. The predominately hyperactive/impulsive subtype of
ADHD is characterized by the presence of six or more of the symptoms related to
hyperactivity/impulsivity in children or five or more of the symptoms in adolescents or
adults. Finally, ADHD – combined type is characterized by the presence of six or more
symptoms in children or five or more symptoms in adolescents or adults related to
inattention and hyperactivity/impulsivity (APA, 2013).
In adulthood, difficulties related to relationship quality, health, legal issues,
unemployment, financial concerns, and academic failure have been found to be more
prevalent among individuals with ADHD (Kessler et al., 2006; Ramsay, 2010a).
Furthermore, ADHD was estimated to result in an excess annual cost of $31.6 billion in
the United States in 2000, specifically $1.6 billion for treatment, $12.1 billion for
additional health care costs, $14.2 billion for additional healthcare costs to families, and
$3.7 billion for work loss costs (Robb et al., 2011).
Assessment of ADHD is often conducted using self-report and other-report
surveys, with the latter based upon information collected from collaterals. Self-report
measures have demonstrated diagnostic validity and allow the patient to report symptoms
as they perceive them (Erhardt, Epstein, Conners, Parker, & Sitarenios, 1999; Kooij et al.,
2008). Given the aforementioned considerations, however, individuals with ADHD
experience deficits in performance monitoring and self-awareness and therefore often
underreport deficits and other symptoms (Erhardt et al., 1999; Kessel & Zimmerman,
1993; Knouse, Bagwell, Barkley, & Murphy, 2005; Prevatt et al., 2011). Other-report
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surveys are often included in the assessment of ADHD to provide supplementary
information to overcome some of these problems (Erhardt et al., 1999; Kessel &
Zimmerman, 1993; Kooij et al., 2008). Ratings of inattention and hyperactivity are often
higher based on an informant report than on a self-report prior to medication treatment,
whereas following medication treatment, self-report and other report scores show a
tendency to converge (Adler et al., 2007; Nelson, 2011; Prevatt et al., 2011).
Incorporation of both self-report and other-report is most often recommended in
assessment of ADHD because each method provides unique information that can
collaboratively inform diagnosis (Goldstein & Ellison, 2002; Kennedy, 2007).
Furthermore, the use of multiple forms of assessment allows the clinician to develop a
more comprehensive understanding of presenting symptoms and implications for
academic, occupational, and social functioning.
Often, assessment of ADHD incorporates direct behavioral measures. Continuous
performance tasks are frequently used because they measure sustained attention. Motionbased continuous performance tasks measure locomotor activity, in addition to
accounting for sustained attention (Conners & Staff, 2000; Sumner, 2010; Teicher,
Lowen, Polcari, Foley, & McGreenery, 2004).
Computer-based continuous performance tasks that account for motion have
recently been incorporated into the assessment of ADHD, as they provide a means of
assessment less susceptible to response bias, demand characteristics, and social
desirability (Goldstein & Ellison, 2002; Hall et al., 2015; Kooij et al., 2008; Sumner,
2010). Such measures are suggested to supplement survey report measures in the interest
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of providing a more comprehensive diagnostic conceptualization (Hall et al., 2015;
Sumner, 2010; Teicher, Polcari, & McGreenery, 2008).
A search of the Google Scholar, PsychInfo, and EBSCO databases failed to find
published research on the relationship between ADHD symptom severity as measured by
a widely used and psychometrically sound, self-report assessment measure, specifically,
the Conners’ Adult ADHD Rating Scale (Conners et al., 2002), and ADHD severity as
measured by an objective, motion-based assessment test, specifically, the Quotient
ADHD System (Sumner, 2010). In contrast, most previous research has measured
ADHD severity using only self- and other-report measures (e.g., Goldstein & Ellison,
2002; Kooij et al., 2008; Mörstedt, Corbisiero, Bitto, & Stieglitz, 2015; Sumner, 2010).
The Quotient ADHD System is an example of an objective computer-based
continuous performance task (CPT). CPTs provide data that is less susceptible to
response bias, demand characteristics, and social desirability (Kooij et al., 2008;
Mörstedt, Corbisiero, Bitto, & Stieglitz, 2015; Teicher, Ito, Glod, & Barber, 1996;
Teicher et al., 2004). In addition, the Quotient ADHD System incorporates motion
measurements into assessment of ADHD, unlike many other continuous performance
task measurements (Conners & Staff, 2000; Stein, Snyder, Rugino, & Hornig, 2016;
Sumner, 2010; Teicher et al., 2004, 2008).
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Literature Review
History of ADHD
ADHD is a neurodevelopmental disorder characterized by problems with
executive functions, including attentional control and inhibitory control, that result in
attention deficits, hyperactivity, and/or impulsivity (Daley, 2006; Solanto, 2015). It is
likely that ADHD has been present among humans throughout recorded history; however,
George Still is credited with the first formal clinical identification of ADHD, referring to
it as a difficulty with “moral control without general impairment of intellect and without
physical disease” (Still & Cantab, 1902, p. 1077). In the 1930s, while working with
children with behavioral disorders, pediatrician Charles Bradley discovered the benefits
of stimulant medications for reducing impulsivity and promoting behavioral self-control
(Bradley, 1937). Bradley noted that children taking Benzedrine appeared “emotionally
subdued without, however, losing interest in their surroundings” (Bradley, 1937, p. 580).
The use of Benzedrine in children with behavioral disorders produced substantial
improvements in academic performance. Bradley noticed that when taking Benzedrine,
children with behavioral disorders were also able to demonstrate more appropriate social
behavior, although he stressed that medication was a temporary solution and did not
correct the underlying problem (Bradley, 1937; Strohl, 2011).
The history of American interest in ADHD can be traced to the encephalitis
epidemic, which occurred between 1917 and 1918. A number of children who survived
the brain infection were left with significant cognitive and behavioral difficulties
(Conners & Staff, 2000; Sumner, 2010; Teicher et al., 1996). During the 1950s,
researchers began to investigate potential neurological mechanisms that may underlie the
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behavioral symptoms of what was then called hyperkinetic impulse disorder and reasoned
that deficits resulted from abnormalities in the central nervous system (CNS) (Laufer,
Denhoff, & Solomons, 1957, pp. 1). At the time, it was suggested that the existence of an
imbalance between subcortical and cortical areas of the brain resulted in diminished
control of the subcortical areas responsible for filtering sensation and thus permitted
stimulation from sensation to reach the cortex, resulting in overstimulation (Knobel,
Wolman, & Mason, 1959). This was thought to result in increased perception of
extraneous stimuli and hence difficulties in attention (Knobel, Wolman, & Mason, 1959;
Laufer et al., 1957).
The first appearance of a behavioral health disorder resembling what is now
known as ADHD occurred in the second edition of the Diagnostic and Statistical Manual
of Mental Disorders (2nd ed.; DSM−II; American Psychiatric Association, 1975),
referring to it as a hyperkinetic reaction that occurred during childhood. The DSM–III
introduced the term attention deficit disorder (ADD) (American Psychiatric Association,
1980, p. 41-44). The term was then revised to ADHD in the DSM−III−R (American
Psychiatric Association, 1987, p. 50). The DSM−IV was the first to take into account
attention deficits and their occurrence with or without hyperactivity (American
Psychiatric Association, 1994). Currently, the DSM−V specifies several criteria that must
be met to warrant a diagnosis of ADHD (American Psychiatric Association, 2013).
Whereas children and young adolescents must have at least six symptoms of inattention
and/or hyperactivity-impulsivity, older adolescents and adults (ages 17 and older) must
have at least five symptoms of inattention and/or hyperactivity-impulsivity. Moreover, a
diagnosis of ADHD is based on symptoms of predominant inattentiveness, predominant
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hyperactivity-impulsivity, or combined inattention and hyperactivity-impulsivity
(American Psychiatric Association, 2013).
During the mid to late 1990s, neuropsychological research began to examine
variations in brain functioning, especially with regard to the frontal lobe, among those
meeting ADHD symptom criteria. One study examined verbal fluency in the evaluation
of ADHD (Koziol & Stout, 1992). Further investigation was conducted into neurological
mechanisms underlying ADHD, including comparison to reading disabilities in children
(Hall, Halperin, Schwartz, & Newcorn, 1997). Adult ADHD was investigated in terms of
adaptive functioning and comorbidities (Murphy & Barkley, 1996). Another study found
deficits in adults with ADHD in semantic verbal encoding, vigilance, and written
arithmetic tasks (Seidman, Biederman, Weber, Hatch, & Faraone, 1998).
Contemporary understanding of adult ADHD.
ADHD is currently theorized to be a neurodevelopmental psychiatric disorder
with manifestations in biological, psychological, and social domains. According to
Barkley, the origin of such manifestations stems from deficits in behavioral inhibition
and four related executive abilities: working memory, internalization of speech, selfregulation, and reconstitution (1997). Working memory has been defined as “the ability
to keep an item of information in mind in the absence of an external cue and utilize that
information to direct an impending response” (Goldman-Rakic, 1995, p. 57).
Internalization of speech is considered a means to provide description, self-questioning,
and reflection through language (Flavell, Miller, & Miller, 1985). Self-regulation has
been defined as a response that serves to modify the probability of a later consequence
related to the event responded to (Kanfer & Karoly, 1972). Reconstitution is the ability
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to create multiple novel complex alternative response chains in either language or motor
activity (Milner, 1995). Barkley later revised his model to include the following
executive functioning abilities: self-monitoring, organization, planning, initiating and
completing tasks on a timely basis, tracking and shifting tasks, and self-inhibition
(Barkley, 2015).
According to Brown’s theory, ADHD is related to deficits of executive
functioning, specifically activation, focus, effort, emotion, memory, and action (2002).
Activation refers to the ability to organize and prioritize, whereas focus refers to the
ability to sustain attention during tasks. Effort refers to the ability to regulate alertness
and sustained effort. Emotion refers to frustration management and emotional regulation.
Memory refers to utilization of working memory and recall. Finally, action refers to
monitoring and self-regulation (Brown, 2002).
Neuropsychological correlates of adult ADHD.
ADHD is conceived of by some as a dimensional disorder, meaning that
symptoms are not based simply on the binary presence or absence of symptoms, but that
symptoms and corollary problems exist on a continuum. Symptoms may range from the
mild, subclinical to severe ADHD, based on extremes of a continuum of inattentive
and/or hyperactive-impulsive symptoms (Kern, Geier, Sykes, Geier, & Deth, 2015;
Schneider et al., 2010; Stevenson et al., 2005). Recent research has investigated
neuropsychological substrates accounting for variability and symptom presentation in
ADHD. Specifically, symptoms are theorized to result from a breakdown in the topdown control system, a breakdown in bottom-up capacity for attentional capture, or a
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breakdown in top-down regulation of emotion (Nigg, 2015; Nigg, Blaskey, HuangPollock, & Rappley, 2002).
A breakdown in the top-down control system presents as disturbance in executive
functioning and response inhibition. A breakdown in top-down emotional regulation is
thought to present as increased impulsivity (Arnsten & Rubia, 2012; Shaw, Stringaris,
Nigg, & Leibenluft, 2014). Top-down processing deficits are thought to influence
allocation of attention to emotionally arousing stimuli. Some individuals may allocate
increased attention to arousing stimuli, whereas others may allocate decreased attention,
which can present as emotional lability or callousness, respectively (Arnsten & Rubia,
2012; Polier, Vloet, & Herpertz‐Dahlmann, 2012; Shaw et al., 2014). Finally, breakdown
in regulation of negative emotionality is thought to correlate with disturbances in selfconcept and self-esteem (Nigg, 2015). A breakdown in bottom-up attentional capture
presents as diminished alertness, sometimes characterized as sluggish cognitive tempo.
Additionally, other potential neurobiological and neuropsychological explanations
have been proposed, e.g., an abnormality in reward-related circuitry leading to decreased
delay gradients and delay aversion (Sonuga-Barke, 2002). Deficits in nonworking visual
memory, working memory, attentional set shifting, and stop signal inhibition have been
proposed (Nigg, Willcutt, Doyle, & Sonuga-Barke, 2005; Rhodes, Coghill, & Matthews,
2004; Schachar, Mota, Logan, Tannock, & Klim, 2000; Smith, Taylor, Warner Rogers,
Newman, & Rubia, 2002).
In past research, it has been suggested that ADHD symptoms may diminish over
time, although some studies note that this may partly be a function of developmental
changes and acquired coping strategies (Agnew-Blais, Seidman, & Buka, 2013;
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Biederman, Mick, & Faraone, 2000; Faraone, Biederman, & Mick, 2006; Hill &
Schoener, 1996; Ramsay, 2010a, 2010a). Recent studies suggest, however, that the
presentation of ADHD may change but not necessarily diminish (Biederman, Petty,
Evans, Small, & Faraone, 2010; Turgay et al., 2012; Wilens, Biederman, & Spencer,
2002). In addition, the decline in symptoms of ADHD has been found to be greater in
males than in females (Balint et al., 2009; Biederman et al., 2010). Contradictory
evidence suggests symptom persistence is greater in males than in females, however
(Bauermeister et al., 2007). As previously discussed, more recent evidence demonstrates
that ADHD persists across the lifespan. Thus, treatment for ADHD accounts for
developmental challenges and their variation throughout the lifespan (Biederman et al.,
2010; Brod, Schmitt, Goodwin, Hodgkins, & Niebler, 2012; Turgay et al., 2012).
Evidence indicates that ADHD is related to variations in neuropsychological,
neurological, and behavioral domains. As previously discussed, variations in bottom-up
and top-down processing, reward system responsiveness, and executive functioning are
proposed neuropsychological contributors to ADHD symptom presentation.
Furthermore, ADHD is thought to persist across the lifespan as a function of such
variations and neurological variations, which often present as variations in behavior and
associated symptoms of ADHD.
Neurological correlates of adult ADHD.
Structural neurological variations and their association with ADHD have been
well documented among children and adults (Jadidian, Hurley, & Taber, 2015; Keune,
Wiedemann, Schneidt, & Schönenberg, 2015; Krause, la Fougere, Krause, Ackenheil, &
St H, 2005; Mohamed, Börger, Geuze, & van der Meere, 2015; Stevenson et al., 2005;
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Swanson et al., 2000; Thissen et al., 2015; Tian et al., 2008; Yu-Feng et al., 2007).
Functional variations have been observed in individuals with ADHD. Many such
variations are thought to relate to structural abnormalities associated with ADHD
(Arnsten & Rubia, 2012; Kofler et al., 2014; Nigg et al., 2002).
Genetic and phenotypical variations associated with ADHD.
A growing body of evidence indicates that heritable, genetic risk factors
significantly predict many neurological variations associated with ADHD (Daley, 2006;
Franke, 2015; Jadidian et al., 2015; Keune et al., 2015; Mohamed et al., 2015, 2015;
Stevenson et al., 2005; Thissen et al., 2015). For example, individuals with ADHD are
more likely to have phenotypical variations related to dopamine transportation, dopamine
receptor expression, serotonin transportation, and norepinephrine transportation (Daley,
2006; Kim et al., 2006; Kollins et al., 2008; Prince, Wilens, Spencer, & Biederman, 2015;
Thissen et al., 2015; Wu, Xiao, Sun, Zou, & Zhu, 2012). Also implicated among
individuals with ADHD are higher rates of variations in the D4 dopamine receptor gene
(Daley, 2006). Response control has been associated with variations in dopamine
transporter availability in individuals with ADHD, supporting the assertion that dopamine
transportation and receptor expression are central to ADHD (Krause et al., 2005;
Swanson et al., 2000; Volkow et al., 2007; Wu et al., 2012). Moreover, evidence
suggests that abnormalities in dopamine transportation in addition to functioning and
reduced volumetry of the anterior cingulate cortex contribute to the symptom
presentation associated with ADHD, specifically, deficits in reward anticipation, impulse
control, and emotion regulation (Amico, Stauber, Koutsouleris, & Frodl, 2011; Brown et

12
al., 2010; Bush et al., 1999; Castellanos et al., 2008; Fallgatter et al., 2004; Seidman et
al., 2006).
Dopamine transportation and reception in the nucleus accumbens is thought to
influence motivation and goal oriented behavior (Goto & Grace, 2005). A recent study
found that dopamine D2 receptor (D2R) postsynaptic expression enhancement relates to
enhanced motivation in adult mice, supporting this assertion (Trifilieff et al., 2013).
Moreover, a study of adult rats found that following an artificial increase in the
postsynaptic expression of D2R, increased risk proneness and impulsive behavior were
more likely to be expressed (Adriani et al., 2009). Theories of dopamine pathway
variations in ADHD posit that reception and transportation of dopamine in the nucleus
accumbens, including the ventral striatum, may account in part for motivational deficits
noted in ADHD (Bédard et al., 2010; Goto & Grace, 2005; Ikemoto & Panksepp, 1999;
Swanson et al., 2000; Wu et al., 2012).
Structural neurological variations associated with ADHD.
The steroid sulfatase axis (STS) has been associated with ADHD; polymorphisms
in the STS gene were linked to a diagnosis of ADHD (Brookes et al., 2008, 2010; Davies
et al., 2014). A recent study examined the effect of pharmacological modulation of STS
and found that modulation improved response control. Though the STS has not been a
subject of systematic study, it represents an important consideration in the study of
ADHD neurology.
Research indicates that differences in frontal brain asymmetry may relate to both
depressive and ADHD symptoms (Avila, 2011; Jadidian et al., 2015; Keune et al., 2015).
Positive asymmetry refers to increased activation in the left hemisphere relative to the
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right hemisphere, whereas the opposite is true of negative asymmetry (Stevenson et al.,
2005). Individuals with ADHD are more likely to have negative asymmetry, suggesting
excessive behavioral approach tendencies (as opposed to a more cognitive style) and
predisposition to depression (Keune et al., 2015; Mohamed et al., 2015; Stevenson et al.,
2005).
In addition, evidence suggests that variations in the structure of the caudate
nucleus play a role in deficiencies in procedural learning and executive functioning
(Castellanos et al., 1994; Hynd et al., 1993; Volkow et al., 2007). A recent study found
that deficits in executive functioning could, in part, be attributable to deficits in simple
processes or subexecutive functions, such as subvocal articulation or internal speech
(Hale, Bookheimer, McGough, Phillips, & McCracken, 2007).
Similarly, the cerebellum has been the subject of consideration, although it has
not been the subject of systematic study. Some evidence suggests that individuals with
ADHD are more likely to have reductions in the volume of the cerebellum (Bledsoe,
Semrud-Clikeman, & Pliszka, 2009; Carmona et al., 2005; Cortese et al., 2012; Emond,
Joyal, & Poissant, 2009; Frodl & Skokauskas, 2012; Krain & Castellanos, 2006; Tiemeier
et al., 2010; Valera, Faraone, Murray, & Seidman, 2007).
Functional neurological variations associated with ADHD.
Variations in baseline brain activity and oxygenation have been found in both
children and adults with ADHD (Hale et al., 2007; Konrad & Eickhoff, 2010; Tian et al.,
2008; Yu-Feng et al., 2007). Specifically, individuals with ADHD were found to have
decreased lateral prefrontal oxygenation during a working memory task, compared to
non-ADHD peers (Auer, 2008; Ehlis, Bähne, Jacob, Herrmann, & Fallgatter, 2008;
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Schecklmann et al., 2010). A growing body of evidence suggests that difficulties with
response inhibition and inefficient cognitive control are characteristic of ADHD symptom
presentation, theorized to be the province of the frontal cortex (Boonstra, Kooij,
Oosterlaan, Sergeant, & Buitelaar, 2010; Clark et al., 2007; King, Colla, Brass, Heuser, &
von Cramon, 2007; Konishi et al., 1999; McLoughlin et al., 2009; Ridderinkhof, Van
Den Wildenberg, Segalowitz, & Carter, 2004; Rubia, Smith, Brammer, & Taylor, 2003;
Verbruggen & Logan, 2008). Physical exercise has been found to alleviate difficulties
with response inhibition and cognitive control and to increase oxygenation in the
prefrontal cortex in individuals with ADHD (Archer & Garcia, 2014; Archer &
Kostrzewa, 2012; Choi, Han, Kang, Jung, & Renshaw, 2015). Similarly, medication for
ADHD has been associated with increased blood flow and activation in the prefrontal
cortex (Lee et al., 2005; Spalletta et al., 2001). Moreover, recent evidence suggests that
cognitive behavioral therapy (CBT) increases regional functional connectivity strength in
the fronto-parietal network and cerebellum. Increases in functional coupling between
bilateral superior parietal gyrus were found to positively correlate with improvement in
ADHD symptoms following CBT treatment (Wang et al., 2016).
Recent fMRI studies show that dysregulation in alertness levels, such as enhanced
resting state brain activity, disturbed regulation, and disturbed sleep, are associated with
ADHD (Cortese, Konofal, & Lecendreux, 2008; Hale et al., 2007; Tian et al., 2008). One
such study suggested the hypocretin/orexin system, which is implicated in arousal, could
contribute to the observed variations (Cortese et al., 2008).
Electroencephalography (EEG) has been used to assess ADHD since the de novo
device approval in 2013 (U.S. Food and Drug Administration, 2013). Theta to beta ratio
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(TBR) has been investigated as a potential biomarker for ADHD (Arns, Conners, &
Kraemer, 2012; Loo & Arns, 2015; Snyder, Rugino, Hornig, & Stein, 2015). The TBR is
a ratio of slow-wave theta bands to the faster beta bands (Loo & Arns, 2015; Snyder et
al., 2015). EEG-indicated theta band activity is known to reflect cortical slowing or
drowsiness, whereas beta band activity is often reflective of concentration and focused
mental activity (Loo & Arns, 2015). Increases in slow-wave activity and thus a higher
TBR prior to psychopharmocological treatment have been found to be positively
correlated with positive responses to stimulant medication (Arns, Heinrich, & Strehl,
2014; Loo & Arns, 2015). Evidence suggests that individuals with ADHD have greater
levels of theta band waves relative to beta band waves than neurotypical individuals,
although there is some contradictory evidence (Faraone, Bonvicini, & Scassellati, 2014;
Lenartowicz & Loo, 2014; Øgrim, 2014). However, replication of these findings has
proven difficult (Loo & Arns, 2015; Saad, Kohn, Clarke, Lagopoulos, & Hermens, 2015).
The cause is unknown, although one explanation for the increase in TBRs among nonADHD samples is increasing development and use of portable technology (Loo & Arns,
2015).
Finally, individuals with ADHD are more likely to experience sleep disturbances,
which can exacerbate symptoms of ADHD and result in decreased sustained attention,
working memory impairment, and reduced ability to perform tasks that require attention
(Alhola, & Polo-Kantola, 2007; Kolb, & Whishaw, 2005; Schredl, Alm, & Sobanski,
2007). For both neurotypical individuals and those with ADHD, sleep disturbances and
insomnia decrease attentional ability and working memory (Cortese et al., 2006;
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DeCrescenzo, et al., 2015; Gruber et al., 2012; Hoban 2008; Schredl, Alm, & Sobanski,
2007; Kooij et al., 2008).
Behavioral correlates of adult ADHD.
Individuals with ADHD may exhibit differences in behavior from individuals
without ADHD, especially prior to and during execution of tasks that require sustained
attention and effort. Some common examples include the tendency of individuals with
ADHD to engage in more procrastination, aggressive confrontation, and impulsive
decision making than others (Young, 2005). As previously discussed, individuals with
ADHD are often more focused on preparation for a task (i.e., preparing workspace,
avoiding potential obstacles) than the task itself, due to negative asymmetry in the
prefrontal cortex (Avila, 2011; Keune et al., 2015). Thus, without appropriate planning,
these individuals must rely on more reevaluation and adaptation during tasks than
individuals without ADHD (Avila, 2011; Keune et al., 2015). To compound matters,
reevaluation and adaptation are some of the executive functions often lacking in
individuals with ADHD. However, the ability to reevaluate and adapt to a unique
situation has been found to relate to coping ability in individuals with ADHD (Young,
2005; Zametkin & Ernst, 1999). Issues related to reduced self-control, difficulty
planning, and problems processing the long-range consequences of a potential action are
characteristic of ADHD and may produce negative outcomes in many important life
domains, such as financial planning and maintaining physical health (Kessler et al., 2006;
Ramsay, 2010a; Solanto, 2015; Young, 2005).
Research indicates that adults with ADHD are more likely to engage in
dysfunctional health behaviors such as nicotine use, sedentary lifestyle, poor diet, and
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lack of exercise than non-ADHD controls (Combs, Canu, Broman-Fulks, Rocheleau, &
Nieman, 2015; Solanto, 2015; Young, 2005). Individuals with ADHD are also at
increased risk for psychoactive substance use disorders (Biederman et al., 1997; Wilens,
Biederman, Spencer, & Frances, 1994). Research suggests two potential reasons why
ADHD and substance use disorder (SUD) may be related. First, dopamine
neurotransmission plays a central role in current models of ADHD and substance use
models (Bédard et al., 2010; O’Hara et al., 1993; Ray et al., 2010). Second, children of
adults with SUD are more likely to develop psychopathology including ADHD
(Biederman et al., 1992, 1997). Given the aforementioned considerations, similarities in
etiological origin may account for the relation of SUD to ADHD.
Deficits in executive functioning are thought to be central to many symptoms
characteristic of ADHD (Barkley, 1997; Brown, 2002). As mentioned, Brown’s theory
of ADHD posits that deficits in executive functioning, specifically activation, focus,
memory, effort, emotion, and action are contributors to ADHD symptoms (2002).
Alternately, Barkley’s revised model proposes that executive functioning includes selfmonitoring, organization, planning, initiating and completing tasks in a timely basis,
tracking and shifting tasks, and self-inhibition (2015a). Research seems to corroborate
Barkley’s and Brown’s respective theories (Boonstra, Oosterlaan, Sergeant, & Buitelaar,
n.d.; Hall et al., 1997; Solanto, 2015).
Children with ADHD also frequently experience greater difficulty with
motivation and effortful control (Dovis, Van der Oord, Huizenga, Wiers, & Prins, 2015).
Deficits in working memory have been found in children with ADHD, as well (Kofler et
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al., 2014). Adults with ADHD experience heightened perceptions of stress, specifically
when tasked with an activity with a high attentional demand (Combs et al., 2015).
Motivation plays an important role in academic outcomes, and individuals with
ADHD experience greater difficulty with motivation (Linnenbrink & Pintrich, 2002).
Motivation has been found to relate to academic success among students with ADHD and
has been a focus of recent research (Brim & Whitaker, 2000). Research also suggests a
relationship between ADHD and emotional regulation (Barkley, 1997; Brown, 2002; Hall
et al., 1997; Solanto, 2015).
Treatment of ADHD
Cognitive distortions and stress have been associated with ADHD severity; the
latter is generally operationalized as scores on psychometrically sound but subjective
self-report measures (Mitchell et al., 2013; Roberts, 2015 Schmidt, Stark, Carlson, &
Anthony 1998; Strohmeier, 2013). Cognitive behavioral therapy (CBT; Beck 1976) has
been empirically validated as a treatment for ADHD in child, adolescent, and adult
populations (Canu & Wymbs, 2015; Knouse, 2015; Ramsay, 2010c; Ramsay & Rostain,
2011). CBT focuses upon the interplay between thoughts, emotions, and behaviors
(Beck,1976, 2005). Modifying cognitive distortions is a focal point of treatment for CBT
of ADHD (Mitchell et al., 2013; Ramsay, 2010). The origin of these distortions is
thought to be distressing emotions related to functional impairments in attentional ability,
motivation, impulse control, and memory. According to Ramsay (2010), these
impairments can lead to maladaptive compensatory strategies, such as avoidance of
demanding tasks in the aforementioned areas. This pattern can create and maintain
maladaptive beliefs over time. These maladaptive beliefs are thought to be further
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strengthened by the related problematic behaviors (e.g., procrastination and avoidance)
(Ramsay, 2010b). During childhood, individuals with ADHD may receive negative
feedback from others regarding their abilities, which may result in negative feelings
regarding the self by adulthood. Such feelings often lead to negative thoughts, thus
facilitating avoidance behavior and reducing motivation, exacerbating preexisting
difficulties (Ljusberg & Brodin, 2007; Nelson, 2011; Tabassam & Grainger, 2002).
Adults who hold inaccurate perceptions and interpretations of symptoms related to
ADHD may attribute their difficulties to their own moral flaw or personality, which may
facilitate further negative self-evaluation (Dan & Raz, 2012; Nelson, 2011; Tabassam &
Grainger, 2002). Adults with ADHD have higher levels of negative self-views and
pessimism (Dan & Raz, 2012; Nelson, 2011; Ramsay, 2010c).
CBT for ADHD addresses cognitive distortions and often incorporates
psychoeducation to help the client understand the disorder, identify deficits and
symptoms, and more effectively manage deficits and symptoms (Christner, Stewart, &
Freeman, 2007; Ramsay, 2007; Young, 2002). Psychological intervention for ADHD
focuses on the adaptation of the surrounding environment to make accommodations that
facilitate the achievement of success (Ramsay, 2010c; Young, 2002). In addition, CBT
for ADHD focuses on assisting the individual to develop skills necessary to achieve goals
set in therapy and cope with associated deficits and symptoms (Canu & Wymbs, 2015;
Ramsay, 2010c; Young, 2002, 2005). A recent study supports these techniques and
suggests that CBT increases regional functional connectivity strength in the frontoparietal network and cerebellum, the brain regions most often affected by medication
(Wang et al., 2016).
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Pharmacotherapy remains a common first-line treatment for ADHD (Brown & La
Rosa, 2002; Dodson, 2005; Mészáros et al., 2009; Prince et al., 2015). Cognitive therapy
combined with pharmacotherapy is regarded as the most efficacious treatment for ADHD
in adults because the interventions target symptoms (Brown & La Rosa, 2002; Dodson,
2005; Prince et al., 2015; Ramsay, 2010c; Rostain, Jensen, Connor, Miesle, & Faraone,
2015), such as time management, organization, self-esteem, planning, and
procrastination, that are apparently less amenable to treatment with medication (Brown &
La Rosa, 2002; Dodson, 2005; Prince et al., 2015).
Although evidence supports the efficacy of ADHD treatment, challenges in
assessment and diagnosis of ADHD, such as variability in symptom presentation,
symptom overlap with other disorders, and the prevalence of comorbid disorders, pose an
inherent challenge to treatment (Goldstein & Ellison, 2002; Kennedy, 2007;
Shemmassian, 2015). To avoid misdiagnosis of ADHD, multitrait, multimethod
assessment is widely considered an integral component of treatment (Jensen et al., 1999;
Kennedy, 2007; Montano & Weisler, 2011; Shemmassian, 2015).
Presentation of Behavioral and Neurological Variations in ADHD
As previously discussed, behavioral, neuropsychological, and neurological
variations contribute to observable and reported symptoms and deficits. Inhibitory
control is thought to relate to inattentive symptoms as well as to hyperactive and
impulsive symptoms of ADHD (Clark et al., 2007; Lijffijt, Kenemans, Verbaten, & van
Engeland, 2005; Ossmann & Mulligan, 2003; Quay, 1997; Schachar et al., 2000).
Deficits in the inhibition of motor control are thought to relate to
hyperactive/impulsive symptoms, whereas deficits in cognitive inhibition are thought to
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relate to deficits related to inattention (Barkley, 1997; Clark et al., 2007; Ossmann &
Mulligan, 2003; Quay, 1997). Inhibitory control shares involvement with executive
functioning processes and is thought to account in part for deficits in executive
functioning. For example, according to Brown’s model, focus is a component of
executive functioning and requires cognitive inhibition of extraneous stimuli, and
according to Barkley’s model, self-inhibition is considered a direct component of
executive functioning (Barkley, 1997; Brown, 2002).
Difficulty planning, reduced self-control, and difficulty processing the long-range
consequences of a potential action are characteristic of ADHD (Kessler et al., 2006;
Ramsay, 2010b; Solanto, 2015). A recent study found that problems with self-concept
predicted ADHD symptom severity (O’Brien, 2016). In addition, increased likelihood of
being diagnosed with an emotional disorder has been found among individuals with
ADHD; men with ADHD are at risk (28%), whereas women are at even greater risk
(49%) (Rasmussen & Levander, 2009). The risk for suicidal ideation is increased for
individuals with ADHD; specifically, one study found that whereas adolescent males are
at risk (5.9%), adolescent females demonstrate greatly increased risk (17.9%) (Rucklidge
& Tannock, 2001).
ADHD and Psychiatric Comorbidities
ADHD is often comorbid with other psychiatric disorders, including depression,
anxiety, bipolar disorder, oppositional defiance disorder, obsessive-compulsive disorder,
and substance use disorders (Adler et al., 2007; Jensen, 2001; Kennedy, 2007; Kessler et
al., 2006; Klassen, Katzman, & Chokka, 2010; Mayes et al., 2009; Murphy & Barkley,
1996; Shemmassian, 2015; Young, Toone, & Tyson, 2003). Comorbidity may be
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explained as a long-standing history of functional impairment likely to result in low selfesteem and demoralization, causing individuals to avoid certain situations, lack
confidence, anticipate failure, and feel misunderstood (Ramsay, 2010a; Young et al.,
2003). As discussed previously, individuals with ADHD often have deficits in executive
functioning. Deficits in executive functioning may negatively affect self-perceptions as a
function of effects on effortful control and decision-making (Murray & Kochanska,
2002). An analysis from a national comorbidity survey indicated that among individuals
diagnosed with ADHD, 38.3% were diagnosed with a co-occurring mood disorder,
47.1% were diagnosed with a co-occurring anxiety disorder, 15.2% were diagnosed with
a substance disorder, and 19.6% were diagnosed with an impulse control disorder
(Kessler et al., 2006). A reciprocal effect may also exist. For example, whereas the
prevalence of ADHD was estimated to be 6 to 8% of the overall population in 2006, the
national comorbidity survey found that 14% of individuals with social phobia were
diagnosed with ADHD, 25.4% of individuals who were diagnosed with drug dependence
were also diagnosed with ADHD, 22.6% of individuals with dysthymia were also
diagnosed with ADHD, and finally 21.2% of individuals with bipolar disorder were
diagnosed with ADHD (Kessler et al., 2006; Polanczyk, Willcutt, Salum, Kieling, &
Rohde, 2014).
Assessment Techniques for ADHD
The assessment of ADHD typically includes obtaining a complete history of
symptoms and measures of academic, psychological, and neuropsychological functioning
(Adler & Alperin, 2015; Kennedy, 2007; Shemmassian, 2015). The format of these
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measures may be self-report or behavioral, the latter including objective motion-based
measurement.
Self-report measurement used in the assessment of ADHD.
Measurement of ADHD symptoms and related constructs through the use of selfor other-report questionnaires offers the clinician information reflective of the
individual’s perceived functioning beyond current behaviors and often within the scope
of various contexts such as academic, social, and occupational functioning (Adler et al.,
2007; Erhardt et al., 1999; Jiang & Johnston, 2011; Kooij et al., 2008). Whereas selfreport questionnaires elicit information from the patients themselves, other-report
questionnaires elicit information based upon observations of the patients’ family, friends,
acquaintances, significant others, coworkers, or clinician (Kooij et al., 2008). In contrast
to behavioral measures, described below, self-report measures of ADHD rely upon the
reporter for information, which is filtered through subjective perceptions and
interpretations (Erhardt et al., 1999; Kennedy, 2007; Kooij et al., 2008; Shemmassian,
2015; Sumner, 2010; Teicher et al., 1996). Some examples of widely accepted
assessment tools include the Brown Attention−Activation Disorder Scale (BAADS), the
Adult ADHD Self-Report Scale for Screening for Adult Attention-Deficit/Hyperactivity
Disorder version 1.1 (ASRS v1.1), the Barkley Adult ADHD Scale Version IV
(BAARS−IV) and the Conners’ Adult ADHD Rating Scale (CAARS) (Barkley, 2011a;
Brown, 1992; Conners, Erhardt, & Sparrow, 1999; Kessler et al., 2006). The BAADS
consists of 40 self-report items that measure core symptoms of ADHD (Brown, 1992).
The scale assesses five symptom clusters: sustained attention, activation, affect, effortful
control, and memory (Adler, n.d.; Brown, 1992). The CAARS is an ADHD scale
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consisting of 66 self-report items that measure inattention, hyperactivity, impulsivity, and
self-concept (Conners et al., 2002, 1999). The ASRS-v1.1 is a six-item screening tool for
adult ADHD for evaluating patients in a busy primary care setting (Hines, King, & Curry,
2012; Kessler et al., 2005). The BAARS−IV is a 27-item screening tool for ADHD that
incorporates measures of inattention, sluggish cognitive tempo, hyperactivity, and
impulsivity (Barkley, 2011a).
Clinical observation is also frequently used in ADHD assessment. Clinical
observation allows incorporation of behavioral observations, often made by a mental
health professional (Goldstein & Ellison, 2002; Kennedy, 2007; Shemmassian, 2015).
The addition of informant report measures offers further information regarding
observable behavior outside of treatment (Goldstein & Ellison, 2002; Kennedy, 2007;
Kooij et al., 2008; Shemmassian, 2015).
Advantages of subjective/self-report assessment of ADHD.
Self- and other-report instruments are widely used to measure ADHD symptoms
and severity. The benefits of this type of assessment are that it does not require special,
costly equipment or technology, only training, a survey form, and a manual. Thus, this
method often requires less time, personnel, equipment, and expense (Goldstein & Ellison,
2002; Hall et al., 2015; Kennedy, 2007; Kooij et al., 2008; Shemmassian, 2015). Unlike
objective assessment, subjective assessment is able to measure behaviors outside of the
context of the therapy in the experiential context in the individual’s daily life (Kennedy,
2007; Kooij et al., 2008). In addition, self-report questionnaires are capable of measuring
constructs otherwise immeasurable via objective means. Cognitive distortions, for
example, can not be measured using objective assessment.
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Limitations of self- and other-report assessment of ADHD.
Self-report measures of ADHD are often limited in their ability to rule out
explanations other than ADHD for the presenting problem and generally do not include
assessment for other psychiatric disorders, trauma, or significant life events (Erhardt et
al., 1999).
Self- and other reports and even clinical observation are reactive measures and,
therefore, reports may be subject to personal bias and the extent of executive functioning
(Barkley, 1997; Kooij et al., 2008; Solanto, 2015). Thus, ADHD patients completing
self-report measures are likely influenced by cognitive distortions, often found in
individuals with ADHD and related comorbidities, as well as by deficits in executive
functioning, a hallmark of ADHD itself. They may perceive the severity of their ADHD
differently, based on these limitations (Kooij et al., 2008; Mitchell, Benson, Knouse,
Kimbrel, & Anastopoulos, 2013; Ramsay, 2010c; C. Strohmeier, 2013). Many
difficulties and frustrations with ADHD occur publicly, for example (e.g., forgetting an
appointment, difficulty managing tasks at work, not remembering a promise to a friend),
and the resulting negative feedback may heighten perceived deficits. In summary,
answers from respondents to both self- and other reports are filtered through their
subjective interpretations and perceptions (Erhardt et al., 1999; Kennedy, 2007; Kooij et
al., 2008; Shemmassian, 2015; Sumner, 2010; Teicher et al., 1996). Executive functions
can be defined as self-directed actions of an individual used to self-regulate (Barkley,
1997).
For example, individuals with ADHD, and specifically with deficits in executive
functioning, might value education highly, yet have difficulty motivating themselves to
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apply extra effort and behave in a way that is congruent with their beliefs. They might
then report themselves to be more attentive in academic situations than they realistically
tend to bem based on their beliefs about themselves, demonstrating a positive illusory
bias.
Objective measurement used in the assessment of ADHD.
Objective measures of ADHD offer supplementary data to further inform ADHD
assessment and provide information that may be less subject to influence by personal
bias, cognitive distortions, or deficits in self-monitoring (Hall et al., 2015; Heiser et al.,
2004; Stein et al., 2016; Sumner, 2010; Teicher et al., 1996). Continuous performance
tasks (CPT) are often used as objective measures for ADHD. Recently, some CPTs have
incorporated motion-based measurement into their analysis (Edebol, Helldin, &
Norlander, 2013; Heiser et al., 2004; Sumner, 2010; Teicher et al., 1996, 2008). The
incorporation of motion-based measurement into CPT assessments for ADHD provides
additional information based on locomotor activity, which has been shown to relate to
ADHD symptom severity and predict a diagnosis of ADHD (Epstein et al., 2003; Hall et
al., 2015; Losier, McGrath, & Klein, 1996; Teicher et al., 2004; Teicher, Polcari,
Fourligas, Vitaliano, & Navalta, 2012; Teicher et al., 2008).
CPT measures include the Test of Variables of Attention (TOVA), the Gordon
Diagnostic System (GDS), the Conner’s Continuous Performance Test (CCPT), and the
Integrated Visual and Auditory Continuous Performance Task (IVA+CPT) (Conners et
al., 2002; Edebol, Helldin, & Norlander, 2013; Gordon, McClure, & Aylward, 1996; Hall
et al., 2015; Tinius, 2003).
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Examples of motion-based continuous performance tasks (CPTs) include the
Quotient ADHD System (formerly known as the McLean Motion and Attention System
[MMAT] and prior to that as the Optical Tracking and Attention test [OPTAx]) and the
Quantified Behavior (QB), each of which incorporates a measure of both attention and
activity (head movement), in contrast to other CPTs (Edebol et al., 2013; Sumner, 2010).
Although the TOVA, GDS, CCPT, and IVA+CPT seem to have good psychometric
properties (e.g., test-retest reliability), they do not include a motion parameter, whereas
the Quotient and QB Test do (Chae, Kim, & Noh, 2003; Hall et al., 2015; Heiser et al.,
2004; Kim et al., 2015; Losier, McGrath, & Klein, 1996; Matier, Halperin, Sharma,
Newcorn, & Sathaye, 1992; Mayes et al., 2009; Wang et al., 2011).
The QB Test is a motion-based CPT that requires the user to differentiate between
letters that appear on a screen and is effective in differentiating individuals who meet
criteria for ADHD from those who do not (Edebol et al., 2013; Hall et al., 2015).
Similarly, the Quotient ADHD System is a motion-based CPT that has also been found to
be more effective in differentiating individuals who meet the criteria for ADHD than
CPTs that do not include a motion parameter (Hall et al., 2015; Jensen, 2001).
The Quotient ADHD System is a computer-based, noninvasive, objective measure
of ADHD that is usually completed in 15 to 20 minutes, in a single session (Sumner,
2010). The procedure includes a go/no-go task, wherein target stimuli (5-, 6-, and 7pointed stars) and nontarget stimuli (4-pointed stars) appear at a random position on a
computer screen and in a random sequence for 200 ms each, at 2000 ms intervals at a 3:1
ratio (Murillo et al., 2015; Teicher et al., 1996). Subjects are instructed to press a button
with their right hand in response to target stimuli, which comprise about half of the
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stimuli presented (Teicher et al., 1996). Variables measured for the go/no-go task are
percent accuracy, percent omission errors (nonresponse to the occurrence of the target),
percent commission errors (responses made when the target stimuli is not displayed),
reaction time latency (response latency after the target occurrence), reaction time
variability (intra-individual standard deviation [SD] of response times), and coefficient of
variation (response time SD/mean latency) (Murillo et al., 2015; Teicher et al., 1996).
The aforementioned variables provide analysis of response accuracy and response latency
over the duration of the assessment, which previous studies have found to predict ADHD
symptom severity (Epstein et al., 2003; Teicher et al., 1996, 2008; Wang et al., 2011).
The Quotient ADHD System also measures locomotor activity using technology
that detects positional stability in space (i.e., head movements), response accuracy, and
response latency (Murillo et al., 2015; Sumner, 2010; Teicher et al., 2012). The
displacement of a spherical reflector secured with elastic bands on the forehead measures
the movement variables. Movement variables are head movement, which measures the
average number of position changes greater than 1 mm over 4 intervals each 5 minutes in
duration; head immobility duration, which is measured over each 5-minute interval; head
displacement, which is the total distance traveled, in meters, on average during each 5minute interval; head area, referring to the two-dimensional space in which the reflector
moved; head spatial complexity, referring to the fractal complexity of the movement
path, with values of one or two; and head temporal scaling, indexing the frequency of
movement (Murillo et al., 2015; Teicher et al., 1996). In a recent meta-analysis,
significant differences were found between ADHD and non-ADHD participants on
measures of head movement, head displacement, head area, head temporal scaling, and
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reaction time variability, suggesting the importance of the recent addition of motion
variables to objective ADHD assessment (Losier et al., 1996). Moreover, assessment of
motion-based variables provides measurement of hyperactive/impulsive motor activity
and inattention; evidence suggests that this increases the test’s effectiveness with regard
to differentiating individuals who meet criteria for ADHD from those who do not (Edebol
et al., 2013; Hall et al., 2015).
Advantages of objective assessment of ADHD.
Objective assessment of ADHD severity measures observable behaviors such as
the Quotient and thus, may be less reactive, given that it is thought to be less likely to be
influenced by individual perceptions and biases than self-report instruments (Teicher et
al., 2012). Motion-based and continuous performance tasks used to measure ADHD
offer precise measurements of locomotor activity and attentional impairment and allow
signs and symptoms of specific difficulties to be isolated (Hall et al., 2015; Murillo et al.,
2015; Teicher et al., 1996, 2012).
Research indicates that individuals with ADHD frequently engage in cognitive
distortions, which could inform their perceptions, reduce accuracy, or increase ambiguity
of their self-report of symptoms (Kooij et al., 2008; Mitchell et al., 2013; O’Brien, 2016;
Rosenfield, 2004; Strohmeier, Rosenfield, DiTomasso, & Ramsay, n.d.).
Disadvantages of objective assessment of ADHD.
Computer-based objective assessment, such as the Quotient, measures observable
behavior within an artificial environment, usually a treatment or research setting. Thus,
important contextual influences on symptoms may not be present and, therefore, results
may not capture a complete picture of real-world behavior, thereby reducing external
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validity (Riccio & Reynolds, 2001). Additionally, computer-based objective assessment
for ADHD is less useful for measuring daily or routine behavior outside the clinical
setting and cannot measure past behavior (Erhardt et al., 1999; Hall et al., 2015; Heiser et
al., 2004). In addition, the findings of one study suggest that anxiety may play a role in
performance on CPT tests (Epstein, Goldberg, Conners, & March, 1997).
Multitrait multimethod assessment of ADHD.
Construct validity is based on integrated interpretation of evidence, and in
construct validation, the assessment outcome is not directly equated with the construct it
endeavors to measure, but rather is considered one indicator of the construct (Cronbach &
Meehl, 1955; Messick, 1995). Multitrait multimethod assessment of ADHD relies upon
multiple measures to formulate a comprehensive view of related symptoms and
functioning (Calderon & Ruben, 2008; Kennedy, 2007; Shemmassian, 2015).
Research demonstrates that ADHD varies widely in symptom presentation and
symptom severity (Adler, n.d.; Adler & Alperin, 2015; Kennedy, 2007; Mayes et al.,
2009; Ramsay, 2010a; Shemmassian, 2015; Teicher et al., 2012). Attention deficithyperactivity disorder can present as symptoms related to inattention, symptoms related
to hyperactivity/impulsivity, or as a combination of symptoms related to inattention and
to hyperactivity/impulsivity (APA, 2013). In addition to having multiple exclusive sets
of symptom criteria, ADHD symptoms present with varying levels of severity among
individuals with the disorder (Rasmussen & Levander, 2009).
To further complicate assessment, individuals with ADHD tend to engage in
compensatory behaviors that alter the manifestation of ADHD symptoms. (Erhardt et al.,
1999; Kooij et al., 2008; Young, 2005). For example, one person may compensate for
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inattention and distractibility by taking copious notes during conversations (Ramsay,
2010b; Bradley M Rosenfield, Ramsay, & Rostain, 2008). This compensatory strategy
may vary in degree of acceptability, depending on context, e.g., in a business meeting
versus in a casual conversation. However, when asked about distractibility, such an
individual may underreport or even deny inattention (on self-report) because the
compensatory strategy has reduced the severity of the problem or has become so
automatic that he or she may no longer be cognizant of it. In such a case, a behavioral
measure such as the Quotient may be a more valid and reliable measure of attention.
On the other hand, the Quotient would be completely blind to early childhood history of
symptoms, for which self- and other-report measures would be more appropriate.
Moreover, a major goal of ADHD assessment is not only to determine the
presence or absence of ADHD, but also to identify comorbidities (Adler & Alperin, 2015;
Barkley, 2015a; Kennedy, 2007). Given the aforementioned considerations, the
importance of the use of multiple methods across multiple traits is widely recognized to
be necessary for accurate diagnosis (Adler & Alperin, 2015, 2015; Barkley, 2015a;
Calderon & Ruben, 2008; Goldstein & Ellison, 2002; Kennedy, 2007; Shemmassian,
2015).
Purpose of the Study
The purpose of this study was to determine whether ADHD symptom self-report
predicts ADHD symptom severity, as measured by behavioral assessment. Specifically,
this study sought to determine if the Quotient ADHD System is a valid and reliable
measure of ADHD symptoms and if the Quotient correlates with a widely accepted,
psychometrically sound self-report ADHD measure, the CAARS. A comparison of
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objective and self-report measures of ADHD severity may help to clarify the nature of the
relationship between these divergent measures of ADHD. Improved understanding may
inform assessment procedures and improve treatment planning related to adult ADHD.
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Hypotheses
Accordingly, it was hypothesized that:
H1: Self-report measurement of ADHD symptom severity (operationalized as the
CAARS Inattention/Memory Problems, Hyperactivity/Restlessness, and
Impulsivity/Emotional Lability scales) will predict and positively correlate with the
Quotient ADHD System global scaled score metric.
H2: Self-reported inattention/memory problems on the CAARS will predict
behavioral measures of distractibility on the Quotient distracted metric, based on errors of
omission.
H3: Self-reported hyperactive/impulsive symptoms on the CAARS will predict
impulsiveness Quotient scores on impulsiveness metric.
H4: Hyperactivity/Restlessness and Impulsivity/Emotional Lability scale scores
on the CAARS will predict behavioral impulsivity Quotient impulsive metric, based on
errors of commission.
H5: Hyperactivity/Restlessness, Impulsivity/Emotional Lability, and
Inattention/Memory Problems scale scores on the CAARS will predict and behavioral
hyperactivity on the Quotient Motion Global Scale.
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Methods
Research Design
The study used a correlational research design to explore the relationship between
self-report measurement of ADHD symptom and observable behavioral symptoms of
ADHD. Symptom severity was operationalized for the CAARS as the percentile rank
derived from the T score associated with the total raw score of the ADHD Index and the
Inattention/Memory Problems, Hyperactivity/Restlessness, and Impulsivity/Emotional
Lability scales. For the Quotient ADHD System, symptom severity was operationalized
as the percentile rank, comprised of the global scaled score and metrics from the
Attention State Summary report, including the Number of Shifts, Attentive, Impulsive,
and Distracted; and Disengaged scales.
Subjects
Archival data was gathered from 209 adults who participated in assessment and/or
treatment at a university-based, outpatient clinic specializing in the treatment and
research of adult ADHD. The clinic is located in a large northeastern U.S. city. Fees are
mainly private payment and university-based insurance reimbursement. The subjects
included physician-, clinician- and self-referred patients. Data was included in this study
if the subject was between 18 and 88 years old and had completed the Conner’s Adult
ADHD Rating Scale and the Quotient ADHD System assessment. In addition, subjects
had to have been diagnosed with ADHD – predominately inattentive type, ADHD –
predominately hyperactive/impulsive type, or ADHD – combined type, based on a full
developmental interview for relevant history and the DSM–5 diagnostic criteria (APA,
2013). Data for individuals with co-occurring substance abuse disorders and/or psychotic
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disorders, as determined through the clinical interview process at intake, were excluded
from the study. Power analysis for multiple regression with three predictors was
conducted in G*Power to ensure a sufficient sample size using an alpha of .05, a power
of .80, and a medium effect size (f 2 = .015) (Faul, Erdfelder, Buchner, & Lang, 2009).
Based on the aforementioned assumptions, the desired sample size was 77. Data in this
study was collected from 216 archived intake records to allow for incomplete records and
to increase statistical power. Seven records failed to meet the inclusion criteria and were
excluded from the study; 209 records were used for the analysis (N = 209). Data were
analyzed using SPSS v. 25.0.
Measures
Quotient ADHD System.
The Quotient ADHD System is an office-based continuous performance task
developed to provide objective measurements of hyperactivity (ability to maintain
positional stability), sustained attention, and impulsive inhibition, which correlate with
severity and symptom presentation of ADHD and ADHD types with the use of similar
motion-based assessment systems (Sumner 2010, Teicher et al., 2012). When
administered to an adult, the continuous performance task takes approximately 20
minutes to complete (Murillo et al., 2015; Teicher et al., 2004). Test-retest reliability for
the Quotient ADHD System has been established at r = .95 for both accuracy and latency
and r = .91 for the number of microevents (Murillo et al., 2015; Teicher et al., 2008).
Concurrent validity, external validity, construct validity, and predictive validity have yet
to be determined (Murillo et al., 2015). The Motion Analysis report consists of the
following metrics; immobility duration, movements, displacement, area, spatial
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complexity, and temporal scaling. Immobility duration refers to the average time sitting
still and not moving; movements refers to the number of position changes greater than 1
mm; displacement refers to the total distance moved by the marker; area refers to the
total area covered by the markers path; spatial complexity refers to the complexity of the
movement path; and temporal scaling refers to the frequency of movement over time.
The Attention Response Analysis report consists of eight metrics: speed of responses for
non-target hits, speed of responses for target hits, accuracy, omission errors, commission
errors, latency, variability, and coefficient of variance (COV). Speed of responses for
nontarget hits refers to the time elapsed between the presentation of a nontarget stimulus
and a response; speed of responses for target hits refers to the time elapsed between the
presentation of a target stimuli and response; accuracy refers to the percentage of correct
responses; omission errors refers to the percentage of missed targets; commission errors
refers to the percentage of incorrect responses to nontargets; latency refers to the average
time to respond correctly; variability refers to variation in response times to the correct
target, and coefficient of variance (COV.) is a normalized measure of response time
variation. The Attention State report consists of the following metrics: number of shifts,
attentive, impulsive, distracted, and disengaged. Number of shifts is a measure of how
frequently a change in behavioral states occurs over the course of a test (i.e., attentive to
impulsive, attentive to distracted, attentive to disengaged, impulsive to distracted,
impulsive to attentive, impulsive to disengaged, distracted to attentive, distracted to
impulsive, distracted to disengaged, disengaged to attentive, disengaged to impulsive,
disengaged to distracted); the total number of shifts in attention state may range from 0 to
39. The Attentive metric is comprised of the percentage of time wherein subjects
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perform with high accuracy and consistent response latency; specifically, it is based on
the combination of correct and incorrect target and nontarget responses and time to
respond. The Impulsive metric refers to the percentage of time wherein subjects produce
an excessive number of commission errors or are too rapid in their responses. The
Distracted metric refers to the percentage of time wherein subjects make an excessive
number of omission errors or are slow or inconsistent in their responses. The Disengaged
metric refers to the percentage of time in which subjects performed no better than chance.
The Quotient testing report also yields a global scaled score, ranging from 0 to 10, which
indicates the average of the Motion and Attention scaled scores and quantifies the
patient’s overall performance. Motion and Attention scaled scores are calculated from
the six motion metrics and the 13 attention metrics.
Conner’s Adult ADHD Rating Scale – Self-Report: Long Form
(CAARS−S:L).
The CAARS−S:L is a 66-item self-report questionnaire designed to measure core
symptoms of ADHD. The items are organized into four scales (Inattention/Memory
Problems, Hyperactivity/Restlessness, Impulsivity/Emotional Lability, and Problems
With Self-Concept) (Conners et al., 1999). The CAARS–S:L also contains questions to
assess DSM–IV ADHD inattentive symptoms, hyperactive-impulsive symptoms, and total
symptoms. Further, the measure contains an ADHD index that incorporates these.
The CAARS is presented in a checklist format, and each item is rated from 0 (not
at all, never) to 3 (very much, very frequently). Individuals with a T score ≥ 65 on a
given scale are considered to have clinically elevated symptoms in that area. The greater
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the number of scales that indicate clinically relevant elevations, the greater the likelihood
of a clinically significant problem.
Analysis of the internal reliability of the CAARS scale yielded coefficient alphas
for the four scales ranging from .86 to .92 for both males and females, suggesting that the
the scales have excellent internal reliability (Erhardt et al., 1999). Using Pearson
product-moment correlations, the CAARS scales had the following test-retest
correlations: .88 (p < .05) for Inattention, .90 (p < .05) for Hyperactivity/Restlessness, .80
(p < .05) for Impulsivity/Emotional Lability, and .91 (p < .05) for Problems With SelfConcept (Erhardt et al., 1999). The CAARS was compared to the Wender Utah Rating
Scale (WURS). The WURS requires adults to retrospectively report childhood ADHD
symptomatology, whereas the CAARS measures current symptoms. However, the two
scales are expected to relate because ADHD is now considered by many to be a
developmental disorder that persists across the lifespan (Ramsay, 2010b; Ramsey &
Rostain, 2005). Based on the procedures for comparison originally outlined by Kessel
and Zimmerman (1993), a recent study calculated efficiency statistics for the CAARS;
specificity was 87%, sensitivity was 82%, negative predictive power was 83%, positive
predictive power was 87%, false positive rate was 13%, false negative rate was 18%,
kappa was 0.692; and the overall correct classification rate was 85% (Erhardt et al.,
1999). These findings suggest that the CAARS does indeed represent a reliable and valid
measure for ADHD.
Procedure
Archival data was gathered from 216 clinical charts of participants at the
aforementioned specialty clinic. For charts meeting criteria for inclusion in the study, the

39
data relevant to the study was extracted and de-identified by the investigator, and each
participant was assigned a unique identifier. The de-identified data was transferred to a
password-protected electronic database for data analysis. Data consisted of the
completed Quotient (global scaled score percentile rank) and three metrics of the
Attention State results ( Attentive, Impulsive, and Distracted), the CAARS DSM–IV
Hyperactive/Impulsive Symptom Count, and three CAARS scales (Memory Problems,
Hyperactivity/Restlessness, and Impulsivity/Emotional Lability), which were interpreted
based on the associated percentile rank to the T score.

40
Results
Statistical analyses were conducted to determine whether self-report measurement
of ADHD symptom severity predicted observable measurement of ADHD symptom
severity. Additionally, the present study endeavored to determine if increased selfreports of specific symptom subsets of ADHD predicted increased observable ADHD
symptom severity. Self-reported ADHD symptom severity was operationalized as three
dimensions of ADHD symptom subsets (as measured by the CAARS). These were a
cognitive dimension (measuring inattention and memory), a behavioral dimension
(hyperactivity and restlessness), finally a dimension assessing inhibition (impulsivity and
emotional lability). T- scores derived from normative data for the symptom subset
measures were used as values for comparison. Behavioral hyperactivity was
operationalized as an analysis based on six motion metrics from the Quotient ADHD
System (immobility duration, movements, displacement, area, spatial complexity, and
temporal scaling), measured based on motion tracking readings from a sensor worn on
the forehead while engaging in a continuous performance task. These metrics were
analyzed normatively to form a composite metric called the motion tracking scaled score.
The value of this metric was used for comparison to the aforementioned self-report
measures. The motion-based metrics were also used in conjunction with 13 metrics of
CPT performance (speed of responses for non-target hits, speed of responses for target
hits, accuracy, omission errors, commission errors, latency, variability, coefficient of
variation [COV], number of shifts, attentive, impulsive, distracted, and disengaged).
These six motion-based metrics and 13 CPT performance metrics were analyzed
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normatively to produce a global scaled score. The value of the global scaled score was
used to determine a value for the measurement of observable ADHD symptoms.
Table 1 provides the means, standard deviations, range, minimum, and maximum
for the CAARS Inattention/Memory, Hyperactivity/Restlessness, and
Impulsivity/Emotional Lability scales. The Quotient ADHD System’s global scaled
score and motion scaled score are presented in Table 1, as well.

Table 1
Summary Statistics for CAARS Symptom Subset Scale Scores and Quotient ADHD System
Global and Motion-Based Scores
Variable

Range Minimum Maximum

M

SD

69.56

12.41

57.00

33.00

90.00

57.02

11.37

54.00

28.00

82.00

57.95

12.04

59.00

31.00

90.00

Quotient global scaled score

6.04

2.05

8.21

1.19

9.40

Quotient motion scaled score

5.93

2.71

9.55

.11

9.66

CAARS Inattention/Memory
Problems
CAARS Hyperactivity/Restlessness
score
CAARS Impulsivity/Emotional
Lability score
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Statistical Analyses
Demographic analysis.
The sample consisted of 134 males and 75 females, with a mean age of 35 and an
age range of 18 to 72. Participants identified as 82.5% Caucasian, followed by 8.5%
Other, 3.8% African American, 3.3% Hispanic, and 1.9% Asian American. Participants
had a mean education level of 15.8, years with a standard deviation of 2.46. They had a
minimum of 11 years and a maximum of 23 years of education.
It was hypothesized that self-report of the severity of ADHD symptoms, as
measured by the CAARS, would predict the observable severity of ADHD symptoms, as
measured by the Quotient ADHD System global scaled score. We tested for
independence of variables. Table 2 summarizes the correlations, means, and standard
deviations.
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Table 2
Summary of Intercorrelations, Means, and Standard Deviations for Overall Score on the
Quotient ADHD System and Symptom Subset Scales on the CAARS
Measure
1. Quotient ADHD

1

2

3

.033

.268*

.033

--

.268*

.073

--

4

M

SD

.073

6.04

2.05

.341*

.518*

69.56

12.41

.341*

--

.508*

57.02

11.37

.518*

.508*

--

57.95

12.04

System Global
Scaled score
2. CAARS Inattention/
Memory score
3. CAARS
Hyperactivity/
Restlessness score
4. CAARS
Impulsivity/
Emotional Lability
score
*Correlation is significant at the 0.01 level (2-tailed)
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Pearson product-moment correlations identified no significant correlation
between self-reported severity of inattention/memory symptoms and observable ADHD
severity (r = .033). Additionally, no significant correlation was found between selfreported severity of impulsivity/emotional lability symptoms and observable ADHD
severity (r = .073). However, a significant and positive correlation was found between
self-reported severity of hyperactivity/restlessness symptoms and observable severity of
ADHD symptoms (r = .268). Given the lack of correlation for the other variables, a
linear regression analysis was appropriate to determine if self-reported
hyperactivity/restlessness would predict observable severity of ADHD symptoms (Field,
2009).
Additional analyses of assumptions were accordingly conducted (Field, 2009).
Standardized residuals were plotted against standardized predicted values, revealing that
assumptions of homoscedasticity and linearity were met. Specifically, the normality of
the residuals was assessed through an examination of a normal probability plot (see
Figure 1). The normal probability plot, examining observed cumulative percentages to
expected cumulative percentages, supported the assumption of normality.

45

Figure 1. Standardized residuals and standardized predicted values for the Quotient
ADHD System global scaled score.

A linear regression analysis was conducted to identify whether self-reports of
hyperactivity/restlessness would predict observable assessment scores of overall ADHD
symptom severity. The results revealed that increased hyperactivity/restlessness
predicted increased observable symptoms of ADHD.
The results of the linear regression analysis, as shown in Table 2, reveal a
coefficient of correlation of .268 (R = .268), with a coefficient of determination of .072
(R2 = .072). The regression analysis revealed a significant regression, F(1, 208) =
16.051, p = .000 indicating that hyperactivity/restlessness made a significant contribution
to the global presentation of observable ADHD symptoms. This indicates that
approximately 7.2% of the Hyperactivity/Restlessness scale of the CAARS predicted the
Quotient ADHD System global scaled score.
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A Pearson product-moment correlation analysis was conducted to determine if
self-reported inattention/memory problems significantly and positively correlated with
behavioral measures of distractibility (errors of omission). Results indicated a
significantly positive relationship between inattention/memory and observable distracted
attention state (r = .170, r2 = .029; p = .007). Correlations, means, and standard
deviations are presented in Table 3.

Table 3
Linear Regression Statistics for the Quotient ADHD System Global Scaled Score as the
Dependent Variable
Predictor

R

R2

Adjusted

SE of

R2

R2

Estimate

Change

.067

1.975

.072

Variable
CAARS

.268

.072

F Change

df1

df2

Change
16.051

1

208

Hyperactivity/
Restlessness

score

A Pearson product-moment correlation was conducted to determine if increases in
self-reported hyperactive/impulsive symptoms significantly positively and correlated
with observable measurement of impulsiveness. Results indicated no significant
correlation between these measures (r = .108, p = .06). Correlations, means, and standard
deviations are presented in Table 4.

Sig. F

.000
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Table 4
Intercorrelations, Means, and Standard Deviations for the Quotient ADHD System
Distracted Metric and the CAARS Inattentive Memory Scale
Measure
1. Quotient ADHD System

1

2

M

SD

--

.170*

14.26

13.00

.170*

--

69.56

12.42

distracted metric score
2. CAARS Inattentive/Memory
score
*Correlation is significant at the 0.01 level (2-tailed)

Pearson product-moment correlational analyses were conducted to determine if
hyperactivity/restlessness and impulsivity/emotional lability would correlate with
behavioral impulsivity (errors of commission). There was not a significant positive
correlation (r = .010, p = .444) between observable measurement of impulsivity and selfreport measurement of impulsivity/emotional lability. Moreover, observable
measurement of impulsivity and self-report measurement of hyperactive/restlessness did
not have a significant positive correlation (r = .065, p = .174). A significant correlation
was found between self-report measurement of impulsivity/emotional lability and
hyperactivity/restlessness, however (r = .508, r2 = .258 p = .000). Table 5 summarizes
the correlations, means, and standard deviations for hyperactivity/impulsivity,
impulsivity/emotional lability and behavioral impulsivity.
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Table 5
Intercorrelations, Means, and Standard Deviations for the Quotient ADHD System
Impulsive Metric and the CAARS Hyperactive/Impulsive Symptom Scores
Measure
1. Quotient ADHD System

1

2

M

SD

--

.108

43.40

22.25

.108

--

60.77

14.33

impulsive metric
2. CAARS Hyperactive/
Impulsive Symptoms
score

To examine whether scores on scales of hyperactivity/restlessness,
impulsivity/emotional lability, and inattention/memory problems would predict
observable behavioral hyperactivity Pearson correlation analyses and linear regression
analysis were conducted.
As Table 6 shows, the only significant and positive correlation found was
between the self-reported severity of hyperactivity/restlessness symptoms and observable
behavioral hyperactivity (r = .231, r2 = .053; p = .001). Additional significant and
positive correlations were found within self-report measures of ADHD symptom subsets.
Specifically, a significant positive correlation was found between self-report measures of
inattention/memory and hyperactivity/restlessness (r = .341, r2 = .116; p = .000). A
significant positive correlation was also found between self-report measures of
inattention/memory and impulsivity/emotional lability (r = .518, r2 = .268; p = .000).
Finally, a significant positive correlation was found between self-report measures of
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hyperactivity/restlessness and impulsivity/emotional lability (r = .508, r2 = .258; p =
.000). Given the aforementioned considerations, linear regression analysis was necessary
only to determine if self-reported hyperactivity/restlessness would predict observable
severity of ADHD symptoms. Tests of assumptions and multiple linear regression were
met. Table 6 summarizes the correlations, means, and standard deviations for selfreported hyperactivity/restlessness symptoms and observable behavioral hyperactivity.

Table 6
Intercorrelations, Means, and Standard Deviations for the Quotient ADHD System
Impulsive Metric and the CAARS Impulsivity/Emotional Lability and
Hyperactive/Restlessness Symptom Scores
Measure

1

2

3

Quotient impulsive metric

--

.010

CAARS Impulsivity/Emotional

.065

--

M

SD

.065

43.40

22.25

.508*

57.95

12.04

--

57.02

11.37

Lability score
CAARS Hyperactive/Restlessness

.010

.508*

score
*Correlation is significant at the 0.01 level

Standardized residuals were plotted against standardized predicted values,
revealing that assumptions of homoscedasticity and linearity were met. The normality of
the residuals was tested through an examination of a normal probability plot (see Figure
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2). The normal probability plot examining observed cumulative percentages to expected
cumulative percentages supported the assumption of normality.

Figure 2. Standardized residuals and standardized predicted values for the Quotient
ADHD System global scaled score.

A linear regression determined that hyperactivity/restlessness predicted increased
behavioral hyperactivity. As shown in Table 7, the results of the simple regression
analysis revealed a coefficient of correlation of .231 (R = .231), with a coefficient of
determination of .053 (R2 = .053); minimal shrinkage was shown with the adjusted
coefficient of determination (R2 = .049). The regression analysis revealed a significant
regression F(1, 208) = 11.796, p = .001 indicating that the CAARS
Hyperactivity/Restlessness scale explained almost 5% of observable symptoms of
behavioral hyperactivity on the Quotient ADHD System.
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Table 7
Summary of Intercorrelations, Means, and Standard Deviations for the Motion Scaled
Score on the Quotient ADHD System and Symptom Subset Scales on the CAARS
1
Quotient ADHD

--

2

3

-.045

.231*

4
-.004

M

SD

5.93

2.71

System motion
scaled score
CAARS Inattention/

-.045

--

.341*

.518*

69.56

12.41

.341*

--

.508*

57.02

11.37

.518*

.508*

--

57.95

12.04

Memory score
CAARS

.231*

Hyperactivity/
Restlessness score
CAARS Impulsivity/

-.004

Emotional
Lability score
*Correlation is significant at the 0.01 level
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Table 8
Summary of Linear Regression Statistics for the Quotient ADHD System Motion Scaled
Score as the Dependent Variable
Predictor

R

R2

Variable
Hyperactivity/
Restlessness
(CAARS)
score

.231

.053

Adjusted

SE of

R2

R2

Estimate

Change

.049

2.645

.049

F Change

df1

df2

Sig. F
Change

11.796

1

209

.001
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Discussion
This study examined the relationship between self-reported measurement of
ADHD symptom severity, as measured by the Conner’s Adult ADHD Rating Scale
(CAARS), and observable measurement of ADHD symptom severity, as measured by the
Quotient ADHD System. Given previous research supporting a relationship between
self-report measurement of ADHD symptom severity and motion-based ADHD
assessment, similar to the Quotient ADHD System, it was hypothesized that self-report
measurement of ADHD symptom severity would predict motion-based behavioral
measurement of ADHD symptom severity (Hall et al., 2015; Losier et al., 1996; Riccio &
Reynolds, 2001; Teicher et al., 1996).
A comprehensive search of Google Scholar, PsychInfo, and EBSCO databases
failed to find a single study investigating the validity and clinical utility of the Quotient
ADHD System in an adult ADHD population, specifically as a means of supplemental
diagnostic assessment for adults with ADHD. However, some studies identified the
sensitivity of the Quotient ADHD System to medication effects in children with ADHD
(Heiser et al., 2004; Losier et al., 1996). In addition, CPT derived motion-based
assessments, including the OptaX system (past version of the Quotient ADHD System)
and the Test of Variables of Attention (TOVA) have shown sensitivity to ADHD
symptoms in children (Sumner, 2010; Teicher et al., 2008). The QB Test was also found
to be sensitive to ADHD in adults, but lacking in specificity to ADHD subtypes (Edebol
et al., 2013; Lis et al., 2010). Therefore, the present study endeavored to identify
empirical support for the Quotient in the assessment of adults with ADHD and to inform
the clinical utility of this ADHD CPT System.
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Observable and Self-Report Measures of ADHD Symptom Severity
The self-reported severity of hyperactive/restlessness symptoms, as measured by
self-report on the CAARS, predicted 7.2 % of the variance in observable global scaled
scores on the Quotient. However, no significant relationship was identified between selfreported inattention/memory symptoms (CAARS) and the global scaled score (Quotient
ADHD System). Moreover, no relationship was found between self-reported symptoms
of impulsivity/emotional lability (CAARS) and the global scaled score (Quotient). These
findings suggest that Quotient measurement of observable symptoms of ADHD severity
is sensitive to hyperactivity and restlessness, although possibly less sensitive to
symptoms of ADHD related to inattention, memory, emotional lability, and
impulsiveness (CAARS).
This study also found that symptoms related to inattention and memory (as
measured by the Inattention/Memory scale on the CAARS) accounted for 2.9% of the
variance in observable. Finally, hyperactivity and restlessness (as measured by the
Hyperactivity/Restlessness scale on the CAARS) accounted for 5.3% of the variance in
observable behavioral hyperactivity (as measured by the motion scaled score on the
Quotient ADHD System).
Implications
Previous studies of motion-based continuous performance tasks have found that
these measurements are sensitive to ADHD in children. This may be explained by the
current understanding of ADHD and recent findings, which suggest decreased motor
activity with age and frequent reduction in hyperactivity and observable restlessness into
adulthood (Turgay et al., 2012; Wilens et al., 2002).
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Inattention and errors of omission.
The current study found that CAARS self-reported inattention/memory shared a
significant positive correlation with observable measurement of distraction, as measured
by the Quotient ADHD System. Past literature suggests that CPTs are sensitive to adult
groups with a diagnosis of ADHD, but does not address specific subtypes of ADHD
(Riccio & Reynolds, 2001; Teicher et al., 2008). CPT performance tasks require
sustained attention to a task. Individuals with inattentive symptoms of ADHD have
difficulty with such tasks. Thus, lapses in attention or reduced attention may offer an
explanation for increased errors of omission. From a clinical perspective, further
exploration of this potential connection could inform assessment of the ADHD −
predominately inattentive type because CPT assessment could offer quantification of
inattentive symptoms, as well as information on the specific presentation of these deficits.
Identification of an association between ADHD symptom severity, as measured
by self-report and ADHD symptom severity, as measured by motion-based assessment,
contains several implications from a clinical standpoint. Specifically, assessment of
observable behavior circumvents the issues inherent with self-report measures, which are
affected by reporting biases, a well-documented concern among individuals with ADHD
(Adler et al., 2007; Erhardt et al., 1999; Knouse et al., 2005; Kooij et al., 2008; Nelson,
2011; Prevatt et al., 2011). CBT for adult ADHD has gained increasing support in recent
years (Canu & Wymbs, 2015; Ramsay, 2010c, 2012; Ramsay & Rostain, 2011).
Moreover, the use of multimodal, multidimensional, and contextually appropriate
diagnostic assessment is recommended in assessing ADHD, and assessment of
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observable behaviors contributes to a comprehensive assessment (Barkley, Knouse, &
Murphy, 2011; Calderon & Ruben, 2008; Kennedy, 2007).
Hyperactivity, impulsivity, and errors of commission.
The current study found that no significant relationship existed between selfreport of hyperactive/impulsive symptoms (as measured by the CAARS) and observable
measurement of impulsivity using errors of commission (as measured by the Quotient
ADHD System). The Quotient ADHD System determines the Impulsive metric based
upon the frequency of errors of commission (the participant enters an incorrect answer in
a limited time). Although the metric attempts to capture the essence of impulsivity
(action without thinking), no relationship was found between self-reported and
observable measures of impulsivity. Adults with ADHD have difficulty in selfmanagement, including organization, planning, initiating and completing tasks on a
timely basis, tracking and shifting tasks, self-monitoring, and self-inhibition. In the
aggregate, these are executive functions (EFs), which are those self-directed actions
needed to choose goals and to create, enact, and sustain actions toward those goals
(Barkley, 1997; Ramsay, 2010b; Solanto, 2015). This difficulty in self-regulation
typically results in reduced productivity, inefficiency, missed deadlines, poor planning,
careless errors, and losing and forgetting things because of disorganization. In some
cases, reduced inhibitory control may also lead to emotional dysregulation and
inappropriate verbal and/or physical behavior in interpersonal interactions. Over the
lifetime of the individual, these difficulties contribute to failure to achieve goals
personally, academically, and occupationally. These failures, in turn, likely contribute to
the high rates of anxiety and depression in adults with ADHD (Brown, 2002; Solanto,
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2015b; Swanson, 2003). Thus, individuals with ADHD may not exhibit observable
inhibitory control deficits, given the lack of extraneous stimuli or demand on executive
functioning during the continuous performance task offered by the Quotient ADHD
System.
Although these findings are surprising, they may be related to the characteristics
of sample, which consisted of individuals who were more of a higher SES and higher
functioning than the general ADHD population. High levels of functioning, advancing
through college, and maintaining productive and even higher paying employment may
require the ability to inhibit errors of commission that are detectable by the Quotient.
This finding deserves additional investigation and replication of the research.
Discrepancy between self-report and CPT measured impulsivity.
No significant relationship was found between self-reported
hyperactivity/restlessness (as measured by the CAARS) and observable measurement of
impulsivity (as measured by the Quotient ADHD System). No significant positive
relationship was found between self-reported impulsivity/emotional lability (as measured
by the CAARS) and observable impulsivity (as measured by the Quotient ADHD
System). Previous literature suggests a connection between self-reports of ADHD and
observable reports of impulsive symptoms within a CPT task when assessing children
(Heiser et al., 2004; Teicher et al., 2008). No relationship was found using the Quotient
ADHD System Impulsive metric and the Impulsivity/Emotional Lability scale of the
CAARS in the sample of adult participants in the present study. The discrepancy may be
explained by the changes in executive functioning ability developmentally from
childhood to adulthood, as well as changes in coping strategies for deficits in executive
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functioning from childhood to adulthood (Boonstra et al., n.d.; Fischer, Barkley,
Smallish, & Fletcher, 2005; Wilens et al., 2002; Young, 2005). Lack of significance here
may also indicate that the two measures assess distinct manifestations of impulsivity.
Specifically, the Quotient ADHD System motion metrics may indicate a manifestation of
impulsivity that is underrepresented on self-report measures such as the CAARS due to
lack of self-awareness. Specifically, the CAARS requires self-awareness, whereas the
Quotient ADHD System does not.
Self-reported and behavioral hyperactivity.
The present study found that self-reported hyperactivity/restlessness (as measured
by the CAARS) predicted observable measurement of behavioral hyperactivity (as
measured by the motion scaled score of the Quotient ADHD System). In contrast, no
significant relationship was found between self-report measures of inattention/memory
(as measured by the CAARS) and observable measurements of behavioral hyperactivity.
Furthermore, no significant relationship was found between self-reported
impulsivity/emotional lability and observable behavioral hyperactivity (as measured by
the motion scaled score of the Quotient ADHD System).
The findings suggest that observable assessment of behavioral hyperactivity using
the Quotient may be sensitive to hyperactive traits associated with ADHD. This is
supported by the predictive relationship between a widely utilized self-report
measurement of ADHD symptoms and subsets, including hyperactivity/restlessness (the
CAARS Hyperactivity/Restlessness Scale), and motion-based measurement of behavioral
hyperactivity (motion scaled score on the Quotient ADHD System). These findings
suggest that increased behavioral hyperactivity (as measured by the Quotient ADHD
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System) is most directly influenced by symptoms of hyperactivity/restlessness. In
addition, these findings suggest that motion-based measurement may not capture
symptoms related to inattention/memory or impulsivity/emotional lability (as measured
by the CAARS). This shows good sensitivity, as well as convergent and discriminant
validity of the Quotient motion scaled score.
The present study addresses a concern among clinicians as to whether to include
objective assessment of ADHD and the extent to which it should inform case
conceptualization and diagnosis.
Limitations
The current study used archival data, and therefore no direct behavioral
observation interview and assessment were conducted. With the exception of the
Quotient and reports from collaterals, the majority of the data collected for the present
study was gathered from self-report inventories. Challenges to validity inherent in selfreport assessment create additional limitations. In addition, the CAARS–S:L measures
ADHD in accordance with the DSM–IV (Conners et al., 1999) and has not yet been
updated for the DSM–5. Moreover, results may have been impacted by the fact that
individuals with ADHD have been shown to have lower self-awareness and may
underreport their symptoms, as previously discussed (Barkley et al., 2011; Jiang &
Johnston, 2011; Kooij et al., 2008; Nelson, 2011).
Generalizability of the present study’s findings are limited by characteristics of
the sample, which consisted of individuals seeking assessment for ADHD at a universitybased outpatient adult ADHD specialty clinic in a large northeastern city. Subjects were
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high functioning individuals with the financial means to seek assessment and decidedly
higher than average educational levels.
Future Directions
Future studies should investigate in greater detail the value of objective
assessment of ADHD, the extent to which it relates to ADHD symptom severity, and its
relationship to specific subsets of ADHD symptoms (e.g., inattentiveness and
impulsivity/hyperactivity).
Additional investigation as to whether specific scales within the CAARS predict
ADHD symptom severity, as measured by motion-based assessment, may provide
additional information that may further improve assessment and treatment planning.
Investigation of the clinical utility of observable measures of symptom presentation may
address this concern. Moreover, future researchers may wish to compare the Quotient
ADHD System to self-report assessments for ADHD that examine executive functioning
directly, such as the Barkley Deficits in Executive Functioning Scale (Barkley 2011b).
Finally, some results may be attributable to extraneous additional factors, such as
distraction during testing, ADHD medication, and previous treatment. The extent to
which such factors influence outcomes may merit future investigation, as well.
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